PMF PATIENT WEEK
ONLINE IN 2021The buzz around the potential of Precision Medicine continues as new technologies, more powerful computing and our ability to store, share and interpret Big Data increases. Yet with differing healthcare systems, regulatory obstacles, reimbursement challenges, ethical concerns and many more issues, there are a multitude of hurdles to overcome before we will see ubiquitous precision medicine. Of course, the ultimate goal is to achieve clinical implementation of a personalised medicine approach.
It will take the combined efforts of healthcare providers, research, industry, Government and patient groups, as well as harnessing the undoubted potential of technology, to realise the potential of precision medicine. By bringing these groups together we hope to help break down these barriers
Our aim is to facilitate global collaboration in precision medicine – what many see as the key to unlocking the promise of a personalised approach to healthcare. We do this through our events, social media, newsletters and our website. Join us and let’s make a difference together.
To learn more about our upcoming events please click the links or view them all here. For our latest interviews, guest blogs, news and more just scroll down.
“…a great event which surpassed my expectations; one of the best conferences I have been to for yearsVP and Head, Genome Sciences & Technologies, Worldwide R&D Pfizer Inc.
Prof. Ingemar Ernberg, discusses the differences between EBV research and Coronavirus Research
Prof Dr Ingemar Ernberg, Professor at Karolinska Institutet, joined us on February 11, 2021...
FeaturesZoe Martin, speaks about the lag phase effects of Cancer Research funding in the UK due to COVID-19
Zoe Martin, Policy Manager, of Cancer Research UK, joined our panel discussion on February 11, 2021...
FeaturesDr Sheuli Porkess, speaks about how advancements in AI have facilitated cancer research during the pandemic
Dr. Sheuli Porkess, Interim Medical Director, of The Association of the British Pharmaceutical...
FeaturesDr Åslaug Helland, of Oslo University Hospital speaks about IMPRESS Norway
Dr Åslaug Helland, of Oslo University Hospital, joined us for our panel discussion on February...
FeaturesUCLA receives $29million gift to build new centre for Precision Genomic Medicine
The Dr. Allen and Charlotte Ginsburg Center for Precision Genomic Medicine will enable...
NewsThe European Commission announces its ‘Europe’s Beating Cancer Plan
On February 3rd, The European Commission unveiled its ‘Europe’s Beating Cancer Plan’ that sets...
NewsDiscovery of High Levels of Specific Gene Involved in Breast Cancer Growth Could Lead to New Precision Medicine Therapies
A study done by researchers at UT Southerwestern (UTSW) has found that a significant amount of...
NewsGenomics to be embedded into patient care pathways by NHS Genomic Medicine Service Alliances
Henry Ford Health System in the US has opened the Brigitte Harris Cancer Pavilion...
NewsPrecision Medicine vs Lily’s fight for survival
7-year-old Lily and her family have fought tirelessly to find clinical Precision Medicine...
Blog PostsPMF Interviews Dr. Bettina Lundgren, CEO and Managing Director, Danish National Genome Centre
CEO and Managing Director, of the Danish National Genome Centre, insights into the Danish...
Blog PostsPMF Interviews Dr. Toni Andreu, Scientific Director, EATRIS
The next interview in our Nordic Precision Medicine Forum 2020/21 series is one we conducted...
Blog PostsPMF Interviews Dr Valtteri Wirta, Speaker at Nordic Precision Medicine Forum 2020/2021
PMF Interviews Dr Valtteri Wirta, Speaker at the Virtual Nordic Precision Medicine Forum 2020/2021...
Blog PostsPharmacogenomics (PGx): The New Frontier in Medication Use
Pharmacogenomics (PGx) has potential to revolutionize current and future medication therapy....
Blog PostsGENETIC INFORMATION WILL BE PART OF ROUTINE HEALTHCARE IN FINLAND
This short blog and video features Markus Perola, Research Professor at Finland’s National...
Blog Posts